Literature DB >> 8774349

Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology.

D P Harris1, H M Vordermeier, A Arya, K Bogdan, C Moreno, J Ivanyi.   

Abstract

The epitope specificity of T-cell help to B cells and of surface immunoglobulin-mediated B-cell-binding of antigens usually involves topographically distinct antigenic determinants. The possibility of cross-recognition of the same peptide sequence by both T cells and antibodies has been a matter of conflicting opinions. We investigated this subject by detailed mapping of T- and B-cell epitopes within four immunogenic mycobacterial peptides. The identified core sequences of T- and B-cell epitopes showed different topology within each peptide: they were partially overlapping or adjacent in two P38-derived peptides, but entirely overlapping in two P19-derived peptides. The critically important result using the two truncated peptides (P19/67-78 and P19/146-155) containing only the fully overlapping epitope cores was, that they retained full potency for inducing antibody responses. However, despite this desirable overlap of determinants, antipeptide sera failed to block the proliferation of corresponding T-cell hybridomas. We conclude, that our study, in contrast to previous findings, suggests that overlapping topology of T- and B-cell epitopes within synthetic peptides does not necessarily impair B-cell immunogenicity.

Mesh:

Substances:

Year:  1996        PMID: 8774349      PMCID: PMC1456338          DOI: 10.1046/j.1365-2567.1996.d01-673.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  B cell response to T helper cell subsets. II. Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity.

Authors:  M Croft; S L Swain
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

2.  Multi-pin peptide synthesis strategy for T cell determinant analysis.

Authors:  N J Maeji; A M Bray; H M Geysen
Journal:  J Immunol Methods       Date:  1990-11-06       Impact factor: 2.303

3.  B cell response to fresh and effector T helper cells. Role of cognate T-B interaction and the cytokines IL-2, IL-4, and IL-6.

Authors:  M Croft; S L Swain
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

Review 4.  Interactions between immunogenic peptides and MHC proteins.

Authors:  J B Rothbard; M L Gefter
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

5.  The structural requirements for class II (I-Ad)-restricted T cell recognition of influenza hemagglutinin: B cell epitopes define T cell epitopes.

Authors:  C M Graham; B C Barnett; I Hartlmayr; D S Burt; R Faulkes; J J Skehel; D B Thomas
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

6.  Immunogenicity of synthetic peptides derived from the sequences of a Streptococcus mutans cell surface antigen in nonhuman primates.

Authors:  T Lehner; P Walker; L A Bergmeier; J A Haron
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

7.  Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16.

Authors:  S A Comerford; D J McCance; G Dougan; J P Tite
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis.

Authors:  H M Vordemeier; D P Harris; E Roman; R Lathigra; C Moreno; J Ivanyi
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

9.  Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacterium leprae.

Authors:  D P Harris; H M Vordermeier; E Roman; R Lathigra; S J Brett; C Moreno; J Ivanyi
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

10.  Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex.

Authors:  N R Nygard; C Bono; L R Brown; J Gorka; K S Giacoletto; W T Schaiff; M B Graham; D W McCourt; M Kabeer; V L Braciale
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  B cells and antibody production in melanoma.

Authors:  Jessica Da Gama Duarte; Janique M Peyper; Jonathan M Blackburn
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

3.  Predominant recognition of species-specific determinants of the GroES homologues from Mycobacterium leprae and M. tuberculosis.

Authors:  B Chua-Intra; J Ivanyi; A Hills; J Thole; C Moreno; H M Vordermeier
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

4.  Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

Authors:  Jinsong Zhang; S Munir Alam; Hilary Bouton-Verville; Yao Chen; Amanda Newman; Shelley Stewart; Frederick H Jaeger; David C Montefiori; S Moses Dennison; Barton F Haynes; Laurent Verkoczy
Journal:  J Immunol       Date:  2014-01-24       Impact factor: 5.422

5.  Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis.

Authors:  Guglielmo Lucchese; Angela Stufano; Darja Kanduc
Journal:  J Biomed Biotechnol       Date:  2010-06-03

Review 6.  Function and Potentials of M. tuberculosis Epitopes.

Authors:  Juraj Ivanyi
Journal:  Front Immunol       Date:  2014-03-24       Impact factor: 7.561

7.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825

8.  Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.

Authors:  Manas Ranjan Dikhit; Akhilesh Kumar; Sushmita Das; Budheswar Dehury; Ajaya Kumar Rout; Fauzia Jamal; Ganesh Chandra Sahoo; Roshan Kamal Topno; Krishna Pandey; V N R Das; Sanjiva Bimal; Pradeep Das
Journal:  Front Immunol       Date:  2017-12-14       Impact factor: 7.561

9.  The promise of the anti-idiotype concept.

Authors:  Thomas Kieber-Emmons; Bejatohlah Monzavi-Karbassi; Anastas Pashov; Somdutta Saha; Ramachandran Murali; Heinz Kohler
Journal:  Front Oncol       Date:  2012-12-19       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.